Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
4
×
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
cancer immunotherapy
celgene
gene therapy
ipo
merck
migraine
nivolumab
protein degradation
renaissance capital
adaptive biotechnologies
What
ipo
4
×
week
4
×
life
science
bio
biotechs
companies
firms
public
roundup
america
arena’s
biogen
bounty
chose
cig
close
club
comeback
company
continued
continues
convoluted
corner
crop
deals
delivered
democrats
device
dreams
exceeded
expressing
group
haul
head
headaches
healthcare
holding
insurance
ipos
Language
Current search:
week
×
" seattle top stories "
×
" san diego top stories "
×
" seattle blog main "
×
ipo
×
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M